A long-lived luminescent probe to sensitively detect arylamine N-acetyltransferase (NAT) activity of cells

被引:35
|
作者
Terai, Takuya [1 ]
Kikuchi, Kazuya [2 ]
Urano, Yasuteru [3 ]
Kojima, Hirotatsu [4 ]
Nagano, Tetsuo [1 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan
[3] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan
[4] Univ Tokyo, Open Innovat Ctr Drug Discovery, Bunkyo Ku, Tokyo 1130033, Japan
关键词
N-ACETYLTRANSFERASE-1; NAT1; FLUORESCENCE PROBES; CANCER CELLS; MECHANISM; INACTIVATION; ACETYLATION; COMPLEXES; PLATFORM; DESIGN; ASSAY;
D O I
10.1039/c2cc17622j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Arylamine N-acetyltransferase (NAT) is an important phase 11 metabolizing enzyme that influences drug efficacy and adverse effects. Here, we report a long-lived luminescent lanthanide complex as a probe for NAT, employing an intraligand photo-induced electron transfer strategy. The probe shows approximately 100-fold increase of luminescence upon N-acetylation catalyzed by NAT, with relatively high specificity for NAT2 over NAT1. It is the first NAT probe that is suitable for sensitive, homogeneous, and rapid detection of NAT activity of recombinant enzyme or cell lysate, and is expected to be useful for drug discovery and clinical diagnosis.
引用
收藏
页码:2234 / 2236
页数:3
相关论文
共 50 条
  • [1] Arylamine N-acetyltransferase activity in man
    Cascorbi, I
    Brockmöller, J
    Mrozikiewicz, PM
    Müller, A
    Roots, I
    DRUG METABOLISM REVIEWS, 1999, 31 (02) : 489 - 502
  • [2] ARYLAMINE N-ACETYLTRANSFERASE ACTIVITY OF THE HUMAN PLACENTA
    DEREWLANY, LO
    KNIE, B
    KOREN, G
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 269 (02): : 756 - 760
  • [3] Arylamine N-acetyltransferase (NAT2) genotypes in a Turkish population
    Aynacioglu, AS
    Cascorbi, I
    Mrozikiewicz, PM
    Roots, I
    PHARMACOGENETICS, 1997, 7 (04): : 327 - 331
  • [4] Characterisation of the putative operon containing arylamine N-acetyltransferase (NAT) in mycobacteria
    Anderton, MC
    Bhakta, S
    Patrick, AL
    Sim, E
    DRUG METABOLISM REVIEWS, 2004, 36 : 161 - 161
  • [5] Evidence for Arylamine N-Acetyltransferase Activity in the Escherichia coli
    Fang C. Chang
    Jing G. Chung
    Current Microbiology, 1998, 36 : 125 - 130
  • [6] IDENTIFICATION OF ARYLAMINE N-ACETYLTRANSFERASE ACTIVITY IN THE BOVINE LENS
    GAUDET, SJ
    RAZAVI, P
    CAIAFA, GJ
    CHADER, GJ
    CURRENT EYE RESEARCH, 1995, 14 (10) : 873 - 877
  • [7] Evidence for arylamine N-acetyltransferase activity in the Escherichia coli
    Chang, FC
    Chung, JG
    CURRENT MICROBIOLOGY, 1998, 36 (03) : 125 - 130
  • [8] ARYLAMINE N-ACETYLTRANSFERASE (NAT) - PARTIAL-PURIFICATION AND CHARACTERIZATION IN THE BOVINE RETINA
    GAUDET, SJ
    CHADER, GJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1067 - 1067
  • [9] Arylamine N-acetyltransferase 1 (NAT1) genotypes in a Lebanese population
    Dhaini, HR
    Levy, GN
    PHARMACOGENETICS, 2000, 10 (01): : 79 - 83
  • [10] Paeonol promotes arylamine N-acetyltransferase activity in rat liver tumour cells
    Chang, HL
    Chung, JG
    Ho, CC
    Hung, CF
    CYTOBIOS, 1998, 95 (379) : 99 - 110